AstraZeneca PLC Share Price Deutsche Boerse AG
Stocks
ZEG
GB0009895292
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
09:31:03 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 136.75 EUR | -0.29% |
|
-2.03% | -13.20% |
| 08:23pm | Odin Norden rose 3.15 percent in August - Valmet jumped on break-up plans | FW |
| 06:53pm | Carnegie All Cap rose 0.83 percent in August, solid risk appetite | FW |
| Market Cap | 25TCr 21TCr 20TCr 18TCr 34TCr 23,58700Cr 34TCr 2,38400Cr 92TCr 11,96400Cr 93TCr 91TCr 38,00100Cr | P/E 2026 * |
20.4x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 27TCr 23TCr 22TCr 20TCr 37TCr 25,44700Cr 37TCr 2,57200Cr 99TCr 12,90700Cr 1LCr 98TCr 40,99600Cr | EV / Sales 2026 * |
4.2x | EV / Sales 2027 * | 3.86x |
| Free-Float |
96.63% | Yield 2026 * |
2.1% | Yield 2027 * | 2.24% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript : AstraZeneca PLC
| 1 day | -0.29% | ||
| 1 week | -2.03% | ||
| Current month | -2.97% | ||
| 1 month | -0.51% | ||
| 3 months | -12.79% | ||
| 6 months | -18.02% | ||
| Current year | -13.20% |
| 1 week | 134.6 |  | 142.3 |
| 1 month | 134 | | 147.45 |
| Current year | 134 | | 180.45 |
| 1 year | 125 | | 180.45 |
| 3 years | 112.45 | | 180.45 |
| 5 years | 94.11 | | 180.45 |
| 10 years | 47.74 | | 180.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | -2.03% | - | - | 25TCr | |
| +0.07% | -2.44% | +48.26% | +88.27% | 1,00100Cr | |
| +0.07% | -3.15% | +49.33% | +63.87% | 64TCr | |
| +0.86% | +0.11% | +16.58% | +72.26% | 45TCr | |
| -0.38% | -3.59% | +28.24% | +35.57% | 34TCr | |
| -0.09% | -13.54% | +10.08% | +26.87% | 26TCr | |
| -0.43% | -2.48% | -2.07% | +11.48% | 25TCr | |
| -0.72% | -13.03% | +34.50% | +45.30% | 21TCr | |
| -3.44% | -7.51% | -20.08% | -59.58% | 20TCr | |
| -0.68% | -4.80% | +21.97% | +86.59% | 18TCr | |
| Average | -0.48% | -5.53% | +20.76% | +41.18% | 39.18TCr | |
| Weighted average by Cap. | -0.21% | -4.65% | +30.15% | +55.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.33TCr 5.44TCr 5.14TCr 4.68TCr 8.75TCr 6,05200Cr 8.83TCr 61TCr 24TCr 3,07000Cr 24TCr 23TCr 9,75000Cr | 6.69TCr 5.75TCr 5.43TCr 4.95TCr 9.24TCr 6,39600Cr 9.33TCr 65TCr 25TCr 3,24400Cr 25TCr 25TCr 10,30400Cr |
| Net income | 1.2TCr 1.03TCr 975.84Cr 888.99Cr 1.66TCr 1,15000Cr 1.68TCr 12TCr 4.47TCr 58TCr 4.52TCr 4.42TCr 1,85200Cr | 1.38TCr 1.18TCr 1.12TCr 1.02TCr 1.9TCr 1,31600Cr 1.92TCr 13TCr 5.12TCr 67TCr 5.17TCr 5.06TCr 2,12100Cr |
| Net Debt | 1.95TCr 1.67TCr 1.58TCr 1.44TCr 2.69TCr 1,86000Cr 2.71TCr 19TCr 7.23TCr 94TCr 7.3TCr 7.14TCr 2,99600Cr | 1.18TCr 1.01TCr 954.74Cr 869.76Cr 1.63TCr 1,12500Cr 1.64TCr 11TCr 4.38TCr 57TCr 4.42TCr 4.32TCr 1,81200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | €137.40 | +0.18% | 547 |
| 10/26/10 | €137.15 | +0.26% | 1,175 |
| 09/26/09 | €136.80 | -0.87% | 428 |
| 08/26/08 | €138.00 | -1.92% | 620 |
| 07/26/07 | €140.70 | +0.32% | 4,163 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- ZEG Stock
Select your edition
All financial news and data tailored to specific country editions
